Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,2,0.83 [0.72-0.95],0.00887384185729077,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_B12_DEF,Inverse variance weighted,2,0.61 [0.42-0.88],0.00906231769493094,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,2,0.65 [0.46-0.92],0.014297127790806,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,2,0.91 [0.84-0.98],0.016942682996056,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,2,0.43 [0.21-0.87],0.0187819191288095,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,2,0.85 [0.74-0.98],0.0208924717868985,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,2,1.78 [1.06-2.99],0.0279121631518269,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_VASCINT,Inverse variance weighted,2,0.57 [0.34-0.95],0.0307192674071185,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,2,0.84 [0.71-0.98],0.0320934516102857,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,2,0.77 [0.61-0.98],0.0341180962915672,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_URETHRALSTRICT,Inverse variance weighted,2,0.56 [0.33-0.97],0.0378148797828167,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,1.2 [1-1.43],0.0442001542980607,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_FOLATEDEF,Inverse variance weighted,2,0.2 [0.04-0.98],0.047649141967304,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_INOTHER,Inverse variance weighted,2,2.56 [1.01-6.51],0.0486685492195893,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,2,1.66 [1-2.75],0.0493601292727275,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,0.9 [0.81-1],0.0499042772653876,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_CERVICALGIA,Inverse variance weighted,2,0.77 [0.59-1],0.049966019106019,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,2,1.1 [0.99-1.23],0.0713285934436098,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,2,1.14 [0.98-1.33],0.0826716755700692,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,2,0.87 [0.74-1.02],0.0869101643792951,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHARR,Inverse variance weighted,2,1.13 [0.98-1.29],0.0888558649215864,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,2,4.63 [0.72-29.6],0.105297932538009,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,2,0.58 [0.29-1.14],0.115828692254797,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,2,0.8 [0.6-1.06],0.117873981959413,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,0.83 [0.65-1.05],0.124878453699481,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CYSTITIS,Inverse variance weighted,2,0.88 [0.74-1.04],0.125670948869563,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,2,0.65 [0.37-1.13],0.128675705251166,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,2,0.87 [0.73-1.04],0.12871744102993,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_VENTHER,Inverse variance weighted,2,0.82 [0.64-1.06],0.130070702585561,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,2,1.31 [0.92-1.85],0.130659562434687,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,2,0.91 [0.79-1.03],0.143495861144137,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H8_HL_NAS,Inverse variance weighted,2,0.7 [0.44-1.13],0.144901939187174,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,2,0.75 [0.51-1.11],0.147461596374775,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_BILIAOTH,Inverse variance weighted,2,0.72 [0.46-1.13],0.149552190887332,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_SKIN_MUCOUS_MEMBRANE,Inverse variance weighted,2,1.14 [0.95-1.37],0.157437568029064,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,2,0.8 [0.57-1.1],0.171861240517144,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERBLOOD,Inverse variance weighted,2,1.4 [0.85-2.3],0.181975351996912,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,2,0.8 [0.58-1.11],0.182093366611665,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOMYELITIS,Inverse variance weighted,2,0.71 [0.42-1.18],0.184415580058425,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,2,0.63 [0.32-1.25],0.186319061973826,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,2,0.61 [0.28-1.29],0.194138051765377,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,2,0.92 [0.81-1.04],0.196827120632125,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,2,0.89 [0.74-1.06],0.197262526402932,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,2,1.08 [0.96-1.21],0.199892410191136,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,2,0.76 [0.5-1.16],0.200454647534524,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,2,0.79 [0.56-1.13],0.200455101483214,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,2,0.63 [0.31-1.29],0.208100832196054,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LIMBPAIN,Inverse variance weighted,2,0.88 [0.73-1.07],0.213877826583199,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,2,1.2 [0.9-1.61],0.216276045376717,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,2,1.43 [0.81-2.54],0.222095584613889,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,2,1.48 [0.79-2.79],0.222442701898738,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,2,0.75 [0.48-1.2],0.230582340842302,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,2,1.18 [0.9-1.56],0.231167934866072,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,2,0.96 [0.89-1.03],0.235754498212661,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,2,0.79 [0.54-1.17],0.238863702597271,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,2,0.95 [0.87-1.04],0.24155923681128,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,2,2.67 [0.51-13.86],0.242303093814203,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,2,1.13 [0.92-1.39],0.247382424783318,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,2,0.84 [0.62-1.13],0.249149896017794,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,2,0.89 [0.73-1.09],0.26949724957151,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,2,0.93 [0.82-1.06],0.289422499616559,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,2,1.36 [0.77-2.39],0.293868549076607,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,2,0.95 [0.87-1.04],0.299717444817821,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,2,0.95 [0.87-1.04],0.300382708887901,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,2,0.9 [0.73-1.1],0.301216628184535,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,Inverse variance weighted,2,0.91 [0.76-1.09],0.303521065498052,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,2,0.65 [0.29-1.48],0.305616098873697,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_COAGOTHER,Inverse variance weighted,2,1.28 [0.78-2.1],0.321375571122217,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,2,0.45 [0.09-2.19],0.321711807785446,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.87 [0.65-1.16],0.347112717136061,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,2,0.94 [0.82-1.07],0.347538384982216,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,Inverse variance weighted,2,0.9 [0.72-1.13],0.352057724157943,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_GENITOUROTH,Inverse variance weighted,2,0.82 [0.54-1.25],0.353868904185683,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,2,0.89 [0.69-1.14],0.354257727450314,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,2,0.51 [0.13-2.1],0.354536567402866,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,2,1.14 [0.86-1.52],0.355417205336134,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_BIPO,Inverse variance weighted,2,1.14 [0.86-1.51],0.360381489339085,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_INTEST_OTH,Inverse variance weighted,2,1.14 [0.86-1.53],0.365970784290385,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,2,1.36 [0.69-2.67],0.371222410084691,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Inverse variance weighted,2,1.21 [0.8-1.83],0.376880264477525,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOMETPOSTOP,Inverse variance weighted,2,1.3 [0.72-2.34],0.379533226436021,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,2,1.24 [0.75-2.05],0.395020355737431,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DULC,Inverse variance weighted,2,0.84 [0.56-1.26],0.395472485054164,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,2,0.92 [0.77-1.11],0.400069790199676,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,2,0.93 [0.78-1.1],0.401721330000498,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_B_DEF,Inverse variance weighted,2,0.66 [0.25-1.74],0.403505388606373,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHANRECT,Inverse variance weighted,2,1.1 [0.88-1.37],0.420571610821314,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,2,0.95 [0.85-1.07],0.429062246325427,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,2,1.19 [0.78-1.82],0.429737359085368,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,2,0.9 [0.7-1.16],0.434340354061449,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,2,1.33 [0.64-2.76],0.439133875438016,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_HYDRONEPHR,Inverse variance weighted,2,1.16 [0.79-1.7],0.441791742793516,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,2,0.51 [0.09-2.87],0.445276504970044,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,2,1.09 [0.88-1.35],0.447334113416971,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,2,1.11 [0.85-1.43],0.448958126193884,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_GULC,Inverse variance weighted,2,0.9 [0.68-1.19],0.464535496496166,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,2,0.95 [0.81-1.1],0.467942795128456,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,2,1.09 [0.86-1.38],0.469211428471048,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,2,0.77 [0.39-1.55],0.470892138274961,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,2,0.82 [0.47-1.42],0.471510016563563,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_VIRALPNEUMO,Inverse variance weighted,2,1.15 [0.79-1.66],0.474095845462771,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,2,0.93 [0.76-1.14],0.475732273419908,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,2,1.33 [0.6-2.93],0.482962606658421,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,2,1.28 [0.64-2.54],0.48352171511946,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,2,0.93 [0.75-1.15],0.496494897682764,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,2,1.54 [0.43-5.5],0.503876259166915,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,2,0.9 [0.66-1.22],0.506757070607945,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,2,1.36 [0.54-3.43],0.510205211084673,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,2,0.97 [0.88-1.07],0.517405340156923,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,2,0.94 [0.78-1.13],0.518676102843314,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,2,0.88 [0.6-1.29],0.521316398093922,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,2,0.92 [0.71-1.19],0.523433577619399,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,2,1.07 [0.87-1.32],0.524884501253186,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,2,0.97 [0.89-1.06],0.524978985370308,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H8_OTHEREAR,Inverse variance weighted,2,1.04 [0.92-1.18],0.536180056317909,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,2,0.73 [0.27-2.02],0.54838117476037,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,2,0.81 [0.4-1.62],0.549178434331404,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,2,1.07 [0.85-1.35],0.549229811381853,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,2,0.97 [0.88-1.07],0.552132030314528,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,2,0.94 [0.75-1.17],0.559592508355531,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,2,0.98 [0.9-1.06],0.565656441125322,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,2,1.04 [0.9-1.2],0.572150283522818,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,2,0.9 [0.64-1.28],0.572869161406559,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,2,0.97 [0.87-1.08],0.573863036804844,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,2,0.95 [0.78-1.15],0.58709248278478,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPEROSMHNAT,Inverse variance weighted,2,0.72 [0.22-2.39],0.593398432380375,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,2,0.9 [0.62-1.32],0.595168165707568,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,2,0.95 [0.79-1.14],0.596592231273208,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,2,0.96 [0.82-1.12],0.600193991517207,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,2,0.94 [0.74-1.19],0.602987058574941,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_PANCOTH,Inverse variance weighted,2,0.87 [0.52-1.46],0.604749993162427,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,2,1.15 [0.68-1.95],0.609147610250518,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,2,0.89 [0.55-1.42],0.612968370748716,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,2,1.19 [0.59-2.4],0.619128453852523,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_NOS,Inverse variance weighted,2,0.93 [0.7-1.24],0.619677694943827,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PULMOEDEMA,Inverse variance weighted,2,0.78 [0.29-2.09],0.621582437858941,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,2,1.1 [0.75-1.6],0.62639017459467,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERCONTACT,Inverse variance weighted,2,1.11 [0.72-1.71],0.628930626403884,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,2,1.21 [0.55-2.68],0.630355553107185,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,2,0.85 [0.43-1.68],0.630639690318038,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,2,0.97 [0.86-1.1],0.637633428082562,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,2,0.97 [0.86-1.1],0.644114638722374,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_TIA,Inverse variance weighted,2,1.04 [0.88-1.23],0.647896987069259,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,2,0.96 [0.78-1.17],0.656033392553594,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,2,1.21 [0.53-2.75],0.656259997462258,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,2,0.97 [0.86-1.1],0.661264278486773,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,2,0.84 [0.39-1.83],0.664522032738357,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_RECURANDPERHEAMATUR,Inverse variance weighted,2,1.38 [0.32-6.03],0.665140293658082,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,2,0.96 [0.81-1.14],0.669356250264939,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,2,0.95 [0.73-1.23],0.677110425083109,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PULMEMB,Inverse variance weighted,2,1.06 [0.79-1.43],0.67804278946369,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,2,1.03 [0.88-1.21],0.685166387661539,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,2,0.95 [0.75-1.21],0.687009757274829,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,2,0.98 [0.86-1.1],0.689397216970356,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,2,0.92 [0.6-1.41],0.689801522996517,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,2,0.87 [0.44-1.74],0.692550894926713,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Inverse variance weighted,2,1.05 [0.83-1.33],0.692752568307673,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,2,1.1 [0.69-1.74],0.695640663373855,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,2,1.04 [0.83-1.31],0.702783138835102,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,2,0.96 [0.77-1.2],0.705650076456195,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,2,1.11 [0.64-1.92],0.707386594646616,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OESITIS,Inverse variance weighted,2,1.11 [0.64-1.93],0.707945453737234,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROMBDVTLOW,Inverse variance weighted,2,0.96 [0.76-1.21],0.71049359811186,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,2,1.1 [0.67-1.79],0.712794503039763,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_HERNIA,Inverse variance weighted,2,0.98 [0.89-1.09],0.728386904590047,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,2,1.14 [0.54-2.41],0.728841155723467,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,2,0.98 [0.87-1.1],0.733514756141468,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,2,1.26 [0.33-4.8],0.736426547557121,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,2,0.97 [0.83-1.14],0.741110617943154,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,2,1.14 [0.52-2.5],0.743293634633381,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,2,0.95 [0.71-1.28],0.744135526321023,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,2,0.93 [0.58-1.49],0.750144087487484,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,2,0.97 [0.79-1.18],0.757513273534966,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,0.89 [0.43-1.86],0.762863987758419,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,2,0.98 [0.85-1.12],0.763835988655213,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CYSTKID,Inverse variance weighted,2,0.88 [0.38-2.05],0.76474334245802,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,2,0.96 [0.73-1.26],0.766729830908796,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,2,0.87 [0.32-2.32],0.774757625836104,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CARDMYO,Inverse variance weighted,2,1.04 [0.78-1.39],0.77517167461779,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_ACUTPANC,Inverse variance weighted,2,1.04 [0.79-1.37],0.77810235404442,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,2,0.98 [0.85-1.13],0.786854637988283,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,2,1.06 [0.69-1.63],0.788963693252877,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,2,1.05 [0.72-1.55],0.790478283411455,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,2,1.02 [0.87-1.21],0.790644293660898,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,2,0.96 [0.71-1.3],0.79339499549661,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_ILEUS,Inverse variance weighted,2,1.03 [0.81-1.3],0.830027138928191,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,0.95 [0.59-1.53],0.835848673309447,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,0.88 [0.24-3.19],0.844089981773378,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,2,0.93 [0.45-1.92],0.848255436175046,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,2,1.07 [0.54-2.11],0.852855723656577,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,2,1.13 [0.28-4.63],0.865024160430893,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,2,0.95 [0.49-1.81],0.86609498445368,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_AORTANEUR,Inverse variance weighted,2,0.98 [0.76-1.27],0.881868868977987,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_KYPHOSIS,Inverse variance weighted,2,1.09 [0.33-3.65],0.886120106658932,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,2,1.05 [0.52-2.12],0.891398444593645,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.98 [0.77-1.26],0.895020450016802,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,2,1.03 [0.69-1.53],0.897644647997126,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,2,1.01 [0.92-1.1],0.898307373395503,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.03 [0.66-1.59],0.901232664190547,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHILEUS,Inverse variance weighted,2,0.98 [0.74-1.31],0.902436735144232,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,2,1.05 [0.51-2.16],0.90437725476617,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,2,0.99 [0.79-1.23],0.904504116290629,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,2,1.05 [0.44-2.55],0.907470972398641,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_VTE,Inverse variance weighted,2,1.02 [0.73-1.41],0.911757215125171,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,2,1 [0.91-1.1],0.921920825951312,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,2,0.98 [0.68-1.41],0.922295292440432,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,2,0.98 [0.64-1.51],0.924800175503996,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,2,1.03 [0.6-1.76],0.927353531077801,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,2,1.02 [0.7-1.48],0.930633801649033,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,2,0.99 [0.69-1.41],0.945323366311495,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,2,1.02 [0.56-1.85],0.946356202368153,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,2,1.01 [0.69-1.48],0.952218670382552,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,2,0.99 [0.67-1.46],0.954362711272557,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,2,0.99 [0.66-1.49],0.954917576525315,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,2,1.01 [0.67-1.52],0.957407054668549,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,2,1.01 [0.8-1.27],0.959821337391243,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CARDMYOOTH,Inverse variance weighted,2,1.01 [0.65-1.57],0.96728488176562,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,2,1 [0.87-1.15],0.975725230855897,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,2,1 [0.88-1.15],0.978715879350908,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,2,1.01 [0.64-1.59],0.981225040115183,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,2,1 [0.88-1.14],0.982069052947811,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,2,1 [0.69-1.47],0.982184426532652,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,2,0.99 [0.6-1.65],0.982414287620513,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,2,1 [0.9-1.11],0.983835184452526,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,2,1 [0.85-1.17],0.985770473038454,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROM,Inverse variance weighted,2,1 [0.53-1.89],0.99168959825871,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,2,1 [0.88-1.13],0.997428072061984,cis
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,2,1 [0.61-1.64],0.998965581856406,cis
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,7,0.72 [0.58-0.89],0.00272468677023243,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PULMEMB,Inverse variance weighted,7,1.46 [1.14-1.88],0.00285067176611332,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_VTE,Inverse variance weighted,7,1.35 [1.11-1.65],0.00333676236891652,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROM,Inverse variance weighted,7,1.43 [1.09-1.88],0.00893153252877933,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,7,1.18 [1.04-1.34],0.0119174341922792,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,7,1.34 [1.06-1.69],0.0126679937993892,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Inverse variance weighted,7,0.58 [0.38-0.89],0.0132214372589865,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,7,0.8 [0.66-0.96],0.0158308795193997,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,7,0.47 [0.24-0.9],0.023378409024532,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,7,0.21 [0.05-0.85],0.0285624851704617,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,7,0.65 [0.43-0.97],0.0345650542212694,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,7,1.23 [1-1.51],0.0499066894302078,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Inverse variance weighted,7,1.25 [0.99-1.57],0.0591660284475828,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_AORTANEUR,Inverse variance weighted,7,0.75 [0.55-1.02],0.062707913012738,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,7,1.15 [0.99-1.32],0.063961579938823,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,7,0.82 [0.67-1.01],0.0677740315896914,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROMBDVTLOW,Inverse variance weighted,7,1.31 [0.97-1.76],0.0757260520560058,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,7,1.17 [0.97-1.41],0.0919287557872537,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,7,1.23 [0.96-1.59],0.107231867037497,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CARDMYOOTH,Inverse variance weighted,7,1.49 [0.91-2.42],0.109746846993045,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,7,0.82 [0.65-1.05],0.111284338298286,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,7,2.17 [0.83-5.69],0.115258141111689,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,7,4.6 [0.68-31.12],0.11766397642216,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,7,1.1 [0.98-1.24],0.120969354984161,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,7,1.17 [0.96-1.44],0.126356714936422,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,7,1.58 [0.88-2.85],0.126413212499983,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,7,1.35 [0.91-1.98],0.132227343916214,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,7,1.2 [0.95-1.53],0.133225854011311,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,7,0.67 [0.39-1.14],0.136297539681876,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_TIA,Inverse variance weighted,7,1.16 [0.95-1.42],0.13881955491432,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_B_DEF,Inverse variance weighted,7,0.45 [0.15-1.32],0.144678833838134,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,7,1.1 [0.97-1.24],0.146828832289196,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_BIPO,Inverse variance weighted,7,1.24 [0.93-1.65],0.151154785535338,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,7,0.6 [0.3-1.22],0.158529202005898,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,7,0.8 [0.59-1.1],0.164879463988543,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,7,1.16 [0.94-1.42],0.165644618994801,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,7,0.67 [0.37-1.19],0.170049011537024,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,7,1.2 [0.92-1.57],0.17626443669296,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,7,0.94 [0.86-1.03],0.178685202886302,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H8_HL_NAS,Inverse variance weighted,7,0.68 [0.38-1.2],0.185154903653306,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_HERNIA,Inverse variance weighted,7,0.91 [0.78-1.05],0.191387324165296,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,7,0.92 [0.8-1.05],0.192873691247518,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,7,1.06 [0.97-1.17],0.195845809196839,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,7,1.41 [0.83-2.41],0.200574695152348,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPEROSMHNAT,Inverse variance weighted,7,2.36 [0.62-8.94],0.206228969148818,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,7,1.44 [0.82-2.55],0.207298777271863,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,7,0.85 [0.65-1.1],0.215310753073811,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DULC,Inverse variance weighted,7,1.27 [0.87-1.86],0.215317880017266,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,7,0.85 [0.66-1.1],0.220253362726164,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,7,0.86 [0.68-1.09],0.226483517585179,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,7,1.31 [0.85-2.01],0.226790865259863,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,7,0.9 [0.76-1.07],0.236389170540587,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,7,0.79 [0.53-1.17],0.237332020335935,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,7,1.06 [0.96-1.17],0.238233484532638,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,7,1.49 [0.77-2.88],0.239663526004374,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,7,1.3 [0.84-2.03],0.241432677247604,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LIMBPAIN,Inverse variance weighted,7,0.92 [0.81-1.06],0.243589279071177,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,7,0.91 [0.78-1.07],0.260073363781386,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,7,1.26 [0.84-1.88],0.260398916701527,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_VASCINT,Inverse variance weighted,7,1.35 [0.79-2.29],0.269320993961829,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,7,1.19 [0.87-1.63],0.272206421141579,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,7,1.09 [0.94-1.26],0.278348390229985,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,7,1.24 [0.84-1.84],0.285943866033138,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,7,0.95 [0.86-1.05],0.288096345127205,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_GENITOUROTH,Inverse variance weighted,7,0.82 [0.56-1.2],0.303799203066045,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_URETHRALSTRICT,Inverse variance weighted,7,0.74 [0.42-1.33],0.319634044368397,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,7,0.93 [0.82-1.07],0.327262061775875,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_PANCOTH,Inverse variance weighted,7,1.3 [0.77-2.21],0.32815823677978,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,7,1.13 [0.88-1.44],0.330280015832263,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,7,0.83 [0.58-1.2],0.331247287702237,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,7,1.07 [0.93-1.24],0.332371061779415,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOMETPOSTOP,Inverse variance weighted,7,1.21 [0.81-1.81],0.34097512812809,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,7,1.12 [0.89-1.4],0.342344696387601,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,7,0.81 [0.52-1.25],0.342986760520178,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,7,1.58 [0.61-4.11],0.343219384363658,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,7,1.46 [0.67-3.2],0.345343094971448,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_INTEST_OTH,Inverse variance weighted,7,1.22 [0.8-1.86],0.34567857131763,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,7,0.43 [0.08-2.46],0.346156191807005,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,7,0.72 [0.37-1.42],0.349503899799044,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,7,0.93 [0.8-1.08],0.351756068105208,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_BILIAOTH,Inverse variance weighted,7,1.33 [0.72-2.44],0.358736808219576,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,7,0.95 [0.85-1.06],0.358745466092145,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,7,1.29 [0.75-2.24],0.360496812046107,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,7,0.96 [0.87-1.05],0.362968425842093,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,7,1.19 [0.82-1.72],0.368629425118725,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,7,1.14 [0.85-1.54],0.380796132912123,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,7,1.06 [0.92-1.22],0.38750509059771,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,7,0.93 [0.78-1.1],0.388090712646509,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,7,1.26 [0.74-2.14],0.39344458195712,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,7,1.2 [0.79-1.83],0.399288799259632,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_ACUTPANC,Inverse variance weighted,7,0.88 [0.66-1.18],0.399330506536337,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,7,1.26 [0.74-2.14],0.402526512701631,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERCONTACT,Inverse variance weighted,7,1.26 [0.73-2.19],0.404675356461585,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,7,1.29 [0.7-2.36],0.413593760694423,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,7,1.09 [0.88-1.34],0.416592691743786,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CARDMYO,Inverse variance weighted,7,1.13 [0.84-1.52],0.418302971853845,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,7,0.66 [0.24-1.82],0.42113541481723,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,7,0.75 [0.36-1.56],0.437784107563564,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,7,1.08 [0.88-1.33],0.442317208170728,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CYSTKID,Inverse variance weighted,7,1.27 [0.68-2.35],0.450432055177919,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,7,0.83 [0.52-1.35],0.457856807836331,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,7,0.91 [0.71-1.17],0.461012640955687,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,7,0.93 [0.76-1.13],0.464353136975573,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,7,0.84 [0.52-1.36],0.469495800522351,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,7,0.67 [0.23-1.98],0.473984384568472,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,7,1.15 [0.77-1.72],0.482464437754419,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,7,1.15 [0.77-1.72],0.484892771902279,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,7,1.07 [0.88-1.31],0.488976399693496,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,7,1.04 [0.93-1.18],0.489090986080823,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,7,0.97 [0.89-1.06],0.495450061100972,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,7,1.14 [0.78-1.68],0.496101317306619,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_NOS,Inverse variance weighted,7,1.14 [0.78-1.65],0.497706849639501,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,7,1.1 [0.83-1.45],0.499247543813402,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,7,1.58 [0.42-5.95],0.499758288560118,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,7,0.88 [0.6-1.28],0.503599739089248,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,7,1.12 [0.79-1.59],0.512378119621699,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,7,0.96 [0.85-1.09],0.525330027677361,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHARR,Inverse variance weighted,7,1.06 [0.88-1.28],0.527229866218651,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,7,1.07 [0.87-1.3],0.532151585721042,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_ILEUS,Inverse variance weighted,7,1.08 [0.85-1.38],0.533709861976707,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,7,1.28 [0.58-2.81],0.535058930330617,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,7,1.2 [0.67-2.16],0.539161889213294,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,7,1.24 [0.62-2.46],0.540941333438024,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,7,1.03 [0.94-1.14],0.542259541266782,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_B12_DEF,Inverse variance weighted,7,1.23 [0.63-2.4],0.548252148006184,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,7,0.87 [0.54-1.39],0.552163011927982,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,7,1.1 [0.81-1.48],0.552462191831993,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,7,0.87 [0.56-1.36],0.555277158868478,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,7,0.75 [0.29-1.97],0.556831829455631,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERBLOOD,Inverse variance weighted,7,1.17 [0.7-1.95],0.558518217661853,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,7,1.15 [0.72-1.86],0.559422736037099,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_CERVICALGIA,Inverse variance weighted,7,1.14 [0.73-1.79],0.563881538627262,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,7,1.21 [0.62-2.38],0.577079251435505,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,7,0.94 [0.76-1.17],0.586772404773602,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_FOLATEDEF,Inverse variance weighted,7,1.61 [0.28-9.43],0.595164280169967,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,7,0.94 [0.75-1.18],0.598973718317618,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,7,1.12 [0.74-1.69],0.602670645514041,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,7,1.27 [0.5-3.23],0.612929256021997,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,7,1.02 [0.94-1.1],0.615462397737128,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,7,1.03 [0.91-1.17],0.628270560003765,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H8_OTHEREAR,Inverse variance weighted,7,1.03 [0.91-1.17],0.629573190575882,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_HYDRONEPHR,Inverse variance weighted,7,1.11 [0.72-1.73],0.630440959293302,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,7,1.04 [0.87-1.25],0.630864434423659,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,7,1.19 [0.58-2.47],0.636130692850087,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,Inverse variance weighted,7,0.93 [0.69-1.26],0.657422352661474,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,7,0.98 [0.89-1.07],0.657741795793672,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,7,0.93 [0.69-1.27],0.660799775409575,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_VIRALPNEUMO,Inverse variance weighted,7,0.88 [0.49-1.58],0.663854071561992,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,7,0.67 [0.11-4.18],0.666683740039711,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,7,1.08 [0.75-1.56],0.668257127173038,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,7,0.91 [0.58-1.42],0.670155294101674,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,7,1.05 [0.83-1.34],0.673977313515073,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_KYPHOSIS,Inverse variance weighted,7,0.76 [0.22-2.69],0.675502712491309,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,7,1.11 [0.67-1.87],0.678565757685201,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,Inverse variance weighted,7,0.97 [0.84-1.12],0.68011323921112,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,7,1.03 [0.89-1.2],0.683348299103741,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,7,1.03 [0.89-1.2],0.691230101775058,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,0.93 [0.66-1.32],0.698064332764083,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_GULC,Inverse variance weighted,7,0.94 [0.7-1.27],0.698303615876702,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_COAGOTHER,Inverse variance weighted,7,0.9 [0.54-1.51],0.698403522243619,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,7,0.97 [0.84-1.12],0.698515795764007,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,7,0.98 [0.9-1.07],0.703389739069951,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,7,1.12 [0.63-1.98],0.706540892886317,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,7,0.96 [0.78-1.19],0.715773165079512,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,7,0.97 [0.8-1.17],0.716461001694984,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,7,1.11 [0.64-1.92],0.718218989711602,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,7,1.08 [0.7-1.68],0.72487009138013,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOMYELITIS,Inverse variance weighted,7,1.1 [0.64-1.87],0.736398663188288,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHILEUS,Inverse variance weighted,7,1.05 [0.78-1.41],0.740221473504763,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,7,1.02 [0.9-1.16],0.747977653491805,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,7,1.1 [0.62-1.93],0.751055901301788,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,7,1.1 [0.6-2.04],0.751268082540339,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,7,0.76 [0.14-4.06],0.752303406371194,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,7,1.04 [0.79-1.38],0.761742408608439,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_CYSTITIS,Inverse variance weighted,7,1.03 [0.86-1.22],0.776048593205065,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,7,0.94 [0.58-1.5],0.786043766817627,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,7,0.98 [0.81-1.17],0.787563508398719,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,7,0.96 [0.7-1.32],0.795111299661035,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_VENTHER,Inverse variance weighted,7,0.95 [0.64-1.41],0.806146459105013,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,7,0.98 [0.86-1.13],0.8160938530525,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,7,1.09 [0.51-2.31],0.828874180237605,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,7,1.06 [0.63-1.76],0.834250622746385,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,7,1.04 [0.73-1.47],0.837152729110296,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,7,0.98 [0.83-1.16],0.841077371040734,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,7,0.93 [0.48-1.82],0.84129905040951,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,7,0.95 [0.59-1.55],0.842144417875374,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,7,0.93 [0.46-1.89],0.843217050053975,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,7,0.99 [0.87-1.12],0.844445146237352,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,7,0.98 [0.82-1.18],0.848373920110002,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,7,0.99 [0.89-1.11],0.853943676448729,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,7,1.02 [0.86-1.2],0.856754194338854,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,7,1.05 [0.62-1.77],0.858084672528539,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,7,1.05 [0.62-1.76],0.859217071034738,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_PULMOEDEMA,Inverse variance weighted,7,0.91 [0.33-2.55],0.862636958926083,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,7,1.01 [0.91-1.12],0.87394043803877,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,7,1.05 [0.53-2.11],0.882449947583921,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,7,0.98 [0.75-1.28],0.883850453188859,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,7,0.98 [0.74-1.31],0.89971930479974,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,7,1.01 [0.89-1.14],0.900500582058506,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIV Diseases of the genitourinary system,N14_RECURANDPERHEAMATUR,Inverse variance weighted,7,1.13 [0.16-8.13],0.902208393046397,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,7,1.03 [0.63-1.67],0.909907490944237,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,7,1.03 [0.65-1.61],0.91341718003725,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_SKIN_MUCOUS_MEMBRANE,Inverse variance weighted,7,0.98 [0.73-1.32],0.914924807267566,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,7,0.99 [0.85-1.16],0.92003990420757,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,7,0.99 [0.87-1.13],0.926588213074008,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,7,1.01 [0.77-1.33],0.930628591770229,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,7,0.98 [0.64-1.51],0.930975637569425,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,7,0.99 [0.82-1.21],0.933310939782797,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,7,1.01 [0.82-1.24],0.934175541149925,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,7,0.99 [0.78-1.26],0.942974029985444,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,7,0.99 [0.79-1.24],0.948605570728794,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,7,1.03 [0.4-2.67],0.949073684314026,trans
NPDC1,Neural proliferation differentiation and control protein 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,7,1.01 [0.8-1.26],0.960132480501955,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,7,1.02 [0.5-2.07],0.963602038164102,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,7,1 [0.78-1.27],0.968915685844689,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHANRECT,Inverse variance weighted,7,1 [0.79-1.25],0.971962155176133,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,7,0.99 [0.68-1.46],0.972609995780225,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,7,0.99 [0.68-1.45],0.973536970930142,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,7,1.01 [0.59-1.71],0.974220132878621,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,7,0.99 [0.56-1.75],0.978109507271921,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,7,1 [0.92-1.09],0.979360862902742,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,7,1.01 [0.59-1.72],0.979622878334966,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,7,1 [0.86-1.16],0.979672335389588,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,7,1 [0.88-1.14],0.980365970818095,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,7,1 [0.61-1.63],0.987139830357901,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_INOTHER,Inverse variance weighted,7,1.01 [0.38-2.65],0.98808124922308,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,7,1 [0.69-1.45],0.993203770341402,trans
NPDC1,Neural proliferation differentiation and control protein 1,Chapter XI Diseases of the digestive system,K11_OESITIS,Inverse variance weighted,7,1 [0.52-1.94],0.994845271352636,trans
